Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Crism Thera (CRTX) Share Price

Price 11.25p on 16-07-2025 at 10:30:06
Change 0.00p 0%
Buy 12.00p
Sell 10.50p
Buy / Sell CRTX Shares
Last Trade: Sell 65.00 at 10.50p
Day's Volume: 20,065
Last Close: 11.25p
Open: 11.25p
ISIN: VGG042401262
Day's Range 11.25p - 11.25p
52wk Range: 6.25p - 29.00p
Market Capitalisation: £4m
VWAP: 11.59644p
Shares in Issue: 40m

Crism Thera (CRTX) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 65 10.50p SI Trade
11:13:56 - 16-Jul-25
Buy* 20,000 11.60p Ordinary
11:13:54 - 16-Jul-25
Sell* 16 10.575p Ordinary
14:35:52 - 15-Jul-25
Sell* 9,206 10.80p Ordinary
12:41:16 - 15-Jul-25
Buy* 261 11.62p Ordinary
12:15:49 - 15-Jul-25
Sell* 4 10.50p SI Trade
08:33:08 - 15-Jul-25
Sell* 300 10.50p Ordinary
08:33:05 - 15-Jul-25
Sell* 376 10.75p Ordinary
13:40:54 - 14-Jul-25
Sell* 296 10.75p Ordinary
11:27:30 - 14-Jul-25
Sell* 13,809 10.77p Ordinary
08:39:59 - 14-Jul-25
See more Crism Thera trades

Crism Thera (CRTX) Share Price History

Time period:
to
Date Open High Low Close Volume
15th Jul 2025 (Tue) 11.25 11.25 11.25 11.25 9,787
14th Jul 2025 (Mon) 11.25 11.25 11.25 11.25 15,725
11th Jul 2025 (Fri) 11.25 11.25 11.25 11.25 60,950
10th Jul 2025 (Thu) 11.25 11.25 11.25 11.25 214
9th Jul 2025 (Wed) 11.25 11.25 11.25 11.25 36,572
8th Jul 2025 (Tue) 11.25 11.25 11.25 11.25 1,360
7th Jul 2025 (Mon) 11.00 11.25 10.00 11.25 95,124
4th Jul 2025 (Fri) 11.00 11.00 11.00 11.00 57,429
3rd Jul 2025 (Thu) 11.50 11.50 11.00 11.00 82,879
2nd Jul 2025 (Wed) 11.50 11.50 11.50 11.50 86,869
1st Jul 2025 (Tue) 11.50 11.50 11.50 11.50 189,663
30th Jun 2025 (Mon) 15.00 15.00 11.50 11.50 865,905
27th Jun 2025 (Fri) 21.50 21.50 21.00 21.00 24,034
26th Jun 2025 (Thu) 21.50 21.50 21.50 21.50 11,881
25th Jun 2025 (Wed) 21.50 21.50 21.50 21.50 23,423
24th Jun 2025 (Tue) 23.50 23.50 21.50 21.50 48,061
23rd Jun 2025 (Mon) 23.50 23.50 23.50 23.50 4,278
20th Jun 2025 (Fri) 23.50 23.50 23.50 23.50 10,476
19th Jun 2025 (Thu) 23.50 23.50 23.50 23.50 25,670
18th Jun 2025 (Wed) 23.50 23.50 23.50 23.50 3,580
17th Jun 2025 (Tue) 23.50 23.50 23.50 23.50 11,239
16th Jun 2025 (Mon) 24.00 24.00 23.50 23.50 120,263
See more Crism Thera price history

Crism Thera (CRTX) Regulatory News

Date Source Headline
10th Jul 2025 3:04 pm RNS Holding(s) in Company
3rd Jul 2025 7:00 am RNS Result of Retail Offer and Additional Placing
1st Jul 2025 4:41 pm RNS-R Update presentation on the IMC platform
1st Jul 2025 7:00 am RNS Submission of CTA Application
30th Jun 2025 7:01 am RNS Retail Offer
30th Jun 2025 7:00 am RNS Placing
13th Jun 2025 7:00 am RNS Final Results for the year ended 31 December 2024
9th Jun 2025 7:00 am RNS-R Best Paper Award
3rd Jun 2025 7:00 am RNS Establishment of Scientific Advisory Board
7th Apr 2025 11:46 am RNS Director Dealing
See more Crism Thera regulatory news

Crism Thera (CRTX) Share News

LONDON MARKET MIDDAY: London mixed as mortgage data beats expectations

30th Jun 2025 12:01

(Alliance News) - London stocks were mixed at midday on Monday, as US tariff uncertainty continues to weigh on investor sentiment despite a data reading confirming UK economic growth at the start of the year. Read More

AIM WINNERS & LOSERS: MediaZest swings to profit, remains optimistic

30th Jun 2025 11:03

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Monday. Read More

CRISM Therapeutics hails progress in glioblastoma as loss widens

13th Jun 2025 09:43

(Alliance News) - CRISM Therapeutics Corp on Friday said it is confident in its prospects, citing progress in glioblastoma, as it reported an increased loss. Read More

CRISM Therapeutics sets up advisory board ahead of ChemoSeed trial

3rd Jun 2025 12:24

(Alliance News) - CRISM Therapeutics Corp on Tuesday said it has established a scientific advisory board as it prepares to submit a clinical trial application for its lead product, ChemoSeed. Read More

IN BRIEF: CRISM Therapeutics gets European patent for tumour therapy

19th Dec 2024 08:32

CRISM Therapeutics Corp - Surrey-headquartered pharmaceutical firm - Granted a European patent for its lead product ChemoSeed by the European Patent Office. This covers the manufacturing process for the preparation of chemotherapeutic drug implants and their use in therapy, particularly in treating brain tumours such as high grade glioma. ChemoSeed facilitates the local delivery of irinotecan directly to the brain tumour resection site, which allows the delivery of larger doses and reduces systemic concentrations. This alleviates traditional side effects for the patient. Read More

See more Crism Thera news
FTSE 100 Latest
Value8,951.87
Change13.55

Login to your account

Forgot Password?

Not Registered